This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 CM Lawes , S Vander Hoorn & A Rodgers (2008) International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 371, 1513–1518.
2 R Collins , R Peto , S MacMahon , (1990) Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335, 827–838.
3 S MacMahon , R Peto , J Cutler , (1990) Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335, 765–774.
5Prospective Studies Collaboration (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903–1913.
6 NR Cook , J Cohen , PR Hebert , (1995) Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 155, 701–709.
8 MC Houston (2007) Treatment of hypertension with nutraceuticals, vitamins, antioxidants and minerals. Expert Rev Cardiovasc Ther 5, 681–691.
9 GN Thomas , BM Cheung , SY Ho , (2007) Overview of dietary influences on atherosclerotic vascular disease: epidemiology and prevention. Cardiovasc Hematol Disord Drug Targets 7, 87–97.
10 I Rudkowska & PJ Jones (2007) Functional foods for the prevention and treatment of cardiovascular diseases: cholesterol and beyond. Expert Rev Cardiovasc Ther 5, 477–490.
11 BA Murray & RJ FitzGerald (2007) Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production. Curr Pharm Des 13, 773–791.
14 R Lopez-Fandino , J Otte & J van Camp (2006) Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. Int Dairy J 16, 1277–1293.
18 J Sano , K Ohki , T Higuchi , (2005) Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. J Med Food 8, 423–430.
25 K Aihara , O Kajimoto , H Hirata , (2005) Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr 24, 257–265.
28 CD Brown , M Higgins , KA Donato , (2000) Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 8, 605–619.
30 JF Reckelhoff (2001) Gender differences in the regulation of blood pressure. Hypertension 37, 1199–1208.
31 T Jauhiainen , H Vapaatalo , T Poussa , (2005) Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am J Hypertens 18, 1600–1605.
32World Health Organization, International Society of Hypertension Writing Group (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21, 1983–1992.
34 MR Law , NJ Wald , JK Morris , (2003) Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. Br Med J 326, 1427–1431.
35 S Mizushima , K Ohshige , J Watanabe , (2004) Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am J Hypertens 17, 701–706.
37 PM Kearney , M Whelton , K Reynolds , (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365, 217–223.
38 J Tuomilehto , J Lindstrom , J Hyyrynen , (2004) Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension. J Hum Hypertens 18, 795–802.
40 PJ Anderson , JA Critchley & B Tomlinson (1996) A comparison of the pharmacokinetics and pharmacodynamics of cilazapril between Chinese and Caucasian healthy, normotensive volunteers. Eur J Clin Pharmacol 50, 57–62.
41 S Vaidyanathan , J Jermany , C Yeh , (2006) Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects. Br J Clin Pharmacol 62, 690–698.
43 Y Nakamura , N Yamamoto , K Sakai , (1995) Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci 78, 777–783.
46 M Nurminen , M Sipola , H Kaarto , (2000) α-Lactorphin lowers blood pressure via radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci 66, 1535–1543.
47 W Maes , J Van Camp , V Vermeirssen , (2004) Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells. Regul Pept 118, 105–109.
48 T Hirota , K Ohki , R Kawagishi , (2007) Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme. Hypertens Res 30, 489–496.
51 MF Engberink , EG Schouten , FJ Kok , (2008) Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial. Hypertension 51, 399–405.
52 PS Allender , JA Cutler , D Follmann , (1996) Dietary calcium and blood pressure: a meta-analysis of randomized controlled trials. Ann Intern Med 124, 825–831.
53 LE Griffith , GH Guyatt , RJ Cook , (1999) The influence of dietary and nondietary calcium supplementation on blood pressure: an updated meta-analysis of randomized controlled trials. Am J Hypertens 12, 84–92.
54 SH Jee , ER Miller III, E Guallar , (2002) The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens 15, 691–696.
55 LA van Mierlo , LR Arends , MT Streppel , (2006) Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens 20, 571–580.
56 SL Linas (1991) The role of potassium in the pathogenesis and treatment of hypertension. Kidney Int 39, 771–786.
58 P Elliott , H Kesteloot , LJ Appel , (2008) INTERMAP Cooperative Research Group. Dietary phosphorus and blood pressure: international study of macro- and micro-nutrients and blood pressure. Hypertension 51, 669–675.
59 GK Grimble (1994) The significance of peptides in clinical nutrition. Annu Rev Nutr 14, 419–447.
61 BK Bernard , Y Nakamura , I Bando , (2005) Studies of the toxicological potential of tripeptides (l-valyl-l-prolyl-l-proline and l-isoleucyl-l-prolyI-l-proline): II. Introduction. Int J Toxicol 24, Suppl. 4, 5–11.
62 MP Dent , S O'Hagan , WH Braun , (2007) A 90-day subchronic toxicity study and reproductive toxicity studies on ACE-inhibition of lactotripeptide. Food Chem Toxicol 45, 1468–1477.